2005Clinical Misdiagnosis & MistherapyRequires access

Efficacy of Defibrase in Treatment of Progressive Cerebral Infarction

Junmei Li

Open publisher page 0 citations

Abstract

Objective:To explore the clinical efficacy of defibrase in treatment of progressive cerebral infarction.Methods:80 patients with progressive cerebral infarction were randomly divided into defibrase group and control group with 40 patients in each.For control group,patients were treated with dextran,MaiLuoNing and aspirin;to the Defibrase Group,defibrase was administrated for 3 days on the top of routine treatment of dextran,MaiLuoNing and aspirin.The therapeutic effects in the two groups were observed and compared statistically.Results:Compared with the control group,blood lipids and hemodynamic items of defibrase group were improved significantly after the treatment(P0.01);the overall response rate and improvement of nervous functions were greatly raised in defibrase group than in control group(P0.01),Conclusions:On the top of the routine treatment,defibrase would be helpful to improvement and prognosis of patients with progressive cerebral infarction.

About this research paper

What this paper is about

Objective:To explore the clinical efficacy of defibrase in treatment of progressive cerebral infarction.Methods:80 patients with progressive cerebral infarction were randomly divided into defibrase group and control group with 40 patients in each.For control group,patients were treated with dextran,MaiLuoNing and aspirin;to the Defibrase Group,defibrase was administrated for 3 days on the top of routine treatment of dextran,MaiLuoNing and aspirin.The therapeutic effects in the two groups were observed and compared statistically.Results:Compared with the control group,blood lipids and hemodynamic items of defibrase group were improved significantly after the treatment(P0.01);the overall response rate and improvement of nervous functions were greatly raised in defibrase group than in control group(P0.01),Conclusions:On the top of the routine treatment,defibrase would be helpful to improvement and prognosis of patients with progressive cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the clinical efficacy of defibrase in treatment of progressive cerebral infarction.Methods:80 patients with progressive cerebral infarction were randomly divided into defibrase group and control group with 40 patients in each.For control group,patients were treated with dextran,MaiLuoNing and aspirin;to the Defibrase Group,defibrase was administrated for 3 days on the top of routine treatment of dextran,MaiLuoNing and aspirin.The therapeutic effects in the two groups were observed and compared statistically.Results:Compared with the control group,blood lipids and hemodynamic items of defibrase group were improved significantly after the treatment(P0.01);the overall response rate and improvement of nervous functions were greatly raised in defibrase group than in control group(P0.01),Conclusions:On the top of the routine treatment,defibrase would be helpful to improvement and prognosis of patients with progressive cerebral infarction.

Key concepts: Medicine, Aspirin, Cerebral infarction, Anesthesia, Therapeutic effect, Infarction, Brain infarction, Batroxobin

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of Defibrase in Treatment of Progressive Cerebral Infarction — Research Paper | ScholarLens